Tacroz (Proscar ) 0.03% w/v

$8.32

Each 10 gm Tacroz contains .03 % Tacrolimus and is used for moderate to severe atopic eczema unresponsive to conventional therapy.

ATC Classification: D11AX10, G04CB01
Active Ingrediant: Tacrolimus
Generic Name: Tacroz
Manufacturer: GLENMARK
Strength: 0.03% w/v
Dosage Type: Ointment
Packaging Type: Box
Contains: 10 gm

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. WE ARE SHIPPING TO THE USA The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
  2. We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
  3. For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
  4. We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
  5. As things develop we will adjust our shipping prices and operations to best service you.
Thanks for your patience.
Tacroz (Proscar ) 0.03% w/v
Tacroz (Proscar ) 0.03% w/v
$8.32

 

Pronunciation

(fi NAS teer ide)

 

Medication Safety Issues

Sound-alike/look-alike issues:

Finasteride may be confused with dutasteride, furosemide

Proscar may be confused with Prograf, ProSom, Provera, PROzac

 

Storage/Stability

Propecia: Store at 15°C to 30°C (59°F to 86°F). Keep container tightly closed and protect from moisture.

Proscar: Store below 30°C (86°F). Protect from light. Keep container tightly closed.

 

Adverse Reactions

>10%: Genitourinary: Impotence (monotherapy: 5% to 19%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (monotherapy: 9%), peripheral edema (monotherapy: 1%), hypotension (monotherapy: 1%)

Endocrine & metabolic: Decreased libido (monotherapy: 2% to 10%), gynecomastia (monotherapy: 1% to 2%)

Genitourinary: Ejaculatory disorder (monotherapy: <1% to 7%), decreased ejaculate volume (monotherapy: 2% to 4%), sexual disorder (3%), breast tenderness (monotherapy: ≤1%)

Hematologic & oncologic: Prostate cancer (high grade: 2%)

Respiratory: Rhinitis (monotherapy: 1%)

<1%, postmarketing, and/or case reports: Altered mental status, breast hypertrophy, change in libido, depression, hypersensitivity reaction, male infertility (temporary), malignant neoplasm of the breast (men), suicidal ideation (Welk 2017), suicidal tendencies (Welk 2017), testicular pain

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Brand

GLENMARK

Reviews

There are no reviews yet.

Be the first to review “Tacroz (Proscar ) 0.03% w/v”

Your email address will not be published. Required fields are marked *